Abstract
The association of Helicobacter pylori with peptic ulcer disease and gastric cancer was first proposed by Warren and Marshall in 1983 [1]. In February 1994, the National Institutes of Health Consensus Development Conference concluded that H. pylori infection is the major cause of peptic ulcer disease, and all patients with confirmed peptic ulcer disease associated with H. pylori infection should receive treatment with antimicrobial agents [2]. The International Agency for Research on Cancer Working Group of the World Health Organization categorized H. pylori as a group I, or definite, human carcinogen [3]. Based on the data retrieved during the National Health Interview Survey of 1989, 10 % of adult US residents reported physician-diagnosed ulcer disease, among whom one-third had an ulcer in the past year [4]. In developing countries, the prevalence of H. pylori carriers can be as high as 70–90 %. The prevalence of the infection in developed countries is lower, ranging from 25 to 50 % with most patients acquiring the infection at childhood [5]. Seroprevalence studies in adults demonstrated an increasing rate of 3–4 % per decade [3, 6–8].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311–1315
Yamada N (1994) Helicobacter pylori in peptic ulcer disease. NIH Consens Statement 12:1–23
Versalovic J (2003) Helicobacter pylori. Pathology and diagnostic strategies. Am J Clin Pathol 119:403–412
Sonnenberg A, Everhart JE (1996) The prevalence of self-reported peptic ulcer in the United States. Am J Public Health 86:200–205
Dunn BE, Cohen H, Blaser MJ (1997) Helicobacter pylori. Clin Microbiol Rev 10:720–741
Kosunen TU, Aromaa A, Knekt P et al (1997) Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 119:29–34
Cullen DJ, Collins BJ, Christiansen KJ et al (1993) When is Helicobacter pylori infection acquired? Gut 34:1681–1682
Sipponen P, Kosunen TU, Samloff IM, Heinonen OP, Siurala M (1996) Rate of Helicobacter pylori acquisition among Finnish adults: a fifteen year follow-up. Scand J Gastroenterol 31:229–232
O’Connor F, Buckley M, O’Morain C (1996) Helicobacter pylori: the cancer link. J R Soc Med 89:674–678
Isaacson PG (1994) Gastric lymphoma and Helicobacter pylori. N Engl J Med 330:1310–1311
Peterson WL, Fendrick AM, Cave DR, Peura DA, Garabedian-Ruffalo SM, Laine L (2000) Helicobacter pylori-related disease: guidelines for testing and treatment. Arch Intern Med 160:1285–1291
Chey WD, Wong BC (2007) American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 102:1808–1825
Malfertheiner P, Megraud F, O’Morain C et al (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56:772–781
McColl KE (2010) Clinical practice. Helicobacter pylori infection. N Engl J Med 362:1597–1604
Fischbach L, Evans EL (2007) Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment Pharmacol Ther 26:343–357
Malfertheiner P, Schultze V, Rosenkranz B et al (2008) Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study. Gastroenterology 135:787–795
Czinn SJ, Blanchard T (2011) Vaccinating against Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol 8:133–140
Hohl TM, Feldmesser M (2007) Aspergillus fumigatus: principles of pathogenesis and host defense. Eukaryot Cell 6:1953–1963
Dagenais TR, Keller NP (2009) Pathogenesis of Aspergillus fumigatus in invasive Aspergillosis. Clin Microbiol Rev 22:447–465
Philippe B, Ibrahim-Granet O, Prevost MC et al (2003) Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun 71:3034–3042
Ibrahim-Granet O, Philippe B, Boleti H et al (2003) Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect Immun 71:891–903
Segal BH (2009) Aspergillosis. N Engl J Med 360:1870–1884
Daly P, Kavanagh K (2001) Pulmonary aspergillosis: clinical presentation, diagnosis and therapy. Br J Biomed Sci 58:197–205
Walsh TJ, Anaissie EJ, Denning DW et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327–360
Agarwal R (2009) Allergic bronchopulmonary aspergillosis. Chest 135:805–826
Maschmeyer G, Haas A, Cornely OA (2007) Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 67:1567–1601
Patterson TF, Kirkpatrick WR, White M et al (2000) Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 79:250–260
Denning DW (1998) Invasive aspergillosis. Clin Infect Dis 26:781–805
Loffeld RJ, Stobberingh E, Flendrig JA, Arends JW (1991) Helicobacter pylori in gastric biopsy specimens. Comparison of culture, modified giemsa stain, and immunohistochemistry. A retrospective study. J Pathol 165:69–73
Faraker CA (1996) Diagnosis of Helicobacter pylori in gastric brush and biopsy specimens stained by Romanowsky and immunocytochemical methods: comparison with the CLOtest. Cytopathology 7:108–119
Mostaghni AA, Afarid M, Eghbali S, Kumar P (2008) Evaluation of brushing cytology in the diagnosis of Helicobacter pylori gastritis. Acta Cytol 52:597–601
Anim JT, Al-Sobkie N, Prasad A, John B, Sharma PN, Al-Hamar I (2000) Assessment of different methods for staining Helicobacter pylori in endoscopic gastric biopsies. Acta Histochem 102:129–137
Vaira D, Holton J, Menegatti M et al (1999) New immunological assays for the diagnosis of Helicobacter pylori infection. Gut 45(Suppl 1):I23–I27
Guarner J, Kalach N, Elitsur Y, Koletzko S (2010) Helicobacter pylori diagnostic tests in children: review of the literature from 1999 to 2009. Eur J Pediatr 169:15–25
Agha-Amiri K, Mainz D, Peitz U, Kahl S, Leodolter A, Malfertheiner P (1999) Evaluation of an enzyme immunoassay for detecting Helicobacter pylori antigens in human stool samples. Z Gastroenterol 37:1145–1149
Agha-Amiri K, Peitz U, Mainz D, Kahl S, Leodolter A, Malfertheiner P (2001) A novel immunoassay based on monoclonal antibodies for the detection of Helicobacter pylori antigens in human stool. Z Gastroenterol 39:555–560
Suzuki N, Wakasugi M, Nakaya S et al (2002) Catalase, a specific antigen in the feces of human subjects infected with Helicobacter pylori. Clin Diagn Lab Immunol 9:784–788
Suzuki N, Wakasugi M, Nakaya S et al (2002) Production and application of new monoclonal antibodies specific for a fecal Helicobacter pylori antigen. Clin Diagn Lab Immunol 9:75–78
Gisbert JP, Pajares JM (2004) Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review. Helicobacter 9:347–368
Gisbert JP, de la Morena F, Abraira V (2006) Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. Am J Gastroenterol 101:1921–1930
Gramley WA, Asghar A, Frierson HF Jr, Powell SM (1999) Detection of Helicobacter pylori DNA in fecal samples from infected individuals. J Clin Microbiol 37:2236–2240
Nagasawa S, Azuma T, Motani H et al (2009) Detection of Helicobacter pylori (H. pylori) DNA in digestive systems from cadavers by real-time PCR. Leg Med (Tokyo) 11(Suppl 1):S458–459
Kabir S (2004) Detection of Helicobacter pylori DNA in feces and saliva by polymerase chain reaction: a review. Helicobacter 9:115–123
Glocker E, Kist M (2004) Rapid detection of point mutations in the gyrA gene of Helicobacter pylori conferring resistance to ciprofloxacin by a fluorescence resonance energy transfer-based real-time PCR approach. J Clin Microbiol 42:2241–2246
Oleastro M, Gerhard M, Lopes AI et al (2003) Helicobacter pylori virulence genotypes in Portuguese children and adults with gastroduodenal pathology. Eur J Clin Microbiol Infect Dis 22:85–91
Oleastro M, Menard A, Santos A et al (2003) Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori. J Clin Microbiol 41:397–402
Ribeiro ML, Gerrits MM, Benvengo YH et al (2004) Detection of high-level tetracycline resistance in clinical isolates of Helicobacter pylori using PCR-RFLP. FEMS Immunol Med Microbiol 40:57–61
Sugimoto M, Wu JY, Abudayyeh S et al (2009) Unreliability of results of PCR detection of Helicobacter pylori in clinical or environmental samples. J Clin Microbiol 47:738–742
Grocott RG (1955) A stain for fungi in tissue sections and smears using Gomori’s methenamine-silver nitrate technic. Am J Clin Pathol 25:975–979
Hope WW, Walsh TJ, Denning DW (2005) Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 5:609–622
De Vos MM, Nelis HJ (2003) Detection of Aspergillus fumigatus hyphae by solid phase cytometry. J Microbiol Methods 55:557–564
Kaufman L, Standard PG, Jalbert M, Kraft DE (1997) Immunohistologic identification of Aspergillus spp. and other hyaline fungi by using polyclonal fluorescent antibodies. J Clin Microbiol 35:2206–2209
Zimmerman RL, Montone KT, Fogt F, Norris AH (2000) Ultra fast identification of Aspergillus species in pulmonary cytology specimens by in situ hybridization. Int J Mol Med 5:427–429
Horvath JA, Dummer S (1996) The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 100:171–178
Yu VL, Muder RR, Poorsattar A (1986) Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med 81:249–254
Huizinga M, Stevens E, Berrens L (1985) Detection of class-specific antibodies against Aspergillus fumigatus antigens in various pulmonary diseases. Ann Inst Pasteur Immunol 136C:343–352
Tomee JF, van der Werf TS, Latge JP, Koeter GH, Dubois AE, Kauffman HF (1995) Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma. Am J Respir Crit Care Med 151:199–204
Chan CM, Woo PC, Leung AS et al (2002) Detection of antibodies specific to an antigenic cell wall galactomannoprotein for serodiagnosis of Aspergillus fumigatus aspergillosis. J Clin Microbiol 40:2041–2045
Marier R, Smith W, Jansen M, Andriole VT (1979) A solid-phase radioimmunoassay for the measurement of antibody to Aspergillus in invasive aspergillosis. J Infect Dis 140:771–779
Yeo SF, Wong B (2002) Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 15:465–484
Mennink-Kersten MA, Donnelly JP, Verweij PE (2004) Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 4:349–357
Mennink-Kersten MA, Ruegebrink D, Wasei N, Melchers WJ, Verweij PE (2006) In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-beta-d-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J Clin Microbiol 44:1711–1718
Odabasi Z, Mattiuzzi G, Estey E et al (2004) Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 39:199–205
Latge JP, Kobayashi H, Debeaupuis JP et al (1994) Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect Immun 62:5424–5433
Klont RR, Mennink-Kersten MA, Verweij PE (2004) Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis 39:1467–1474
Francis P, Lee JW, Hoffman A et al (1994) Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar d-mannitol and serum galactomannan as markers of infection. J Infect Dis 169:356–368
Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ (2004) Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 190:641–649
Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C, Derouin F (2001) Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 91:311–318
Pazos C, Ponton J, Del Palacio A (2005) Contribution of (1- > 3)-beta-d-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 43:299–305
Jones ME, Fox AJ, Barnes AJ et al (1998) PCR-ELISA for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patients. J Clin Pathol 51:652–656
Kami M, Fukui T, Ogawa S et al (2001) Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 33:1504–1512
Hummel M, Spiess B, Kentouche K et al (2006) Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay. J Clin Microbiol 44:3989–3993
Rickerts V, Mousset S, Lambrecht E et al (2007) Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens. Clin Infect Dis 44:1078–1083
Manolis A (1983) The diagnostic potential of breath analysis. Clin Chem 29:5–15
Cao W, Duan Y (2006) Breath analysis: potential for clinical diagnosis and exposure assessment. Clin Chem 52:800–811
Phillips M (1997) Method for the collection and assay of volatile organic compounds in breath. Anal Biochem 247:272–278
Miekisch W, Schubert JK, Noeldge-Schomburg GF (2004) Diagnostic potential of breath analysis—focus on volatile organic compounds. Clin Chim Acta 347:25–39
Hyspler R, Crhova S, Gasparic J, Zadak Z, Cizkova M, Balasova V (2000) Determination of isoprene in human expired breath using solid-phase microextraction and gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl 739:183–190
Knutson MD, Viteri FE (1996) Concentrating breath samples using liquid nitrogen: a reliable method for the simultaneous determination of ethane and pentane. Anal Biochem 242:129–135
Phillips M, Greenberg J (1992) Ion-trap detection of volatile organic compounds in alveolar breath. Clin Chem 38:60–65
Bazzoli F, Zagari M, Fossi S et al (1997) Urea breath tests for the detection of Helicobacter pylori infection. Helicobacter 2(Suppl 1):S34–S37
Vakil N, Vaira D (2004) Non-invasive tests for the diagnosis of H. pylori infection. Rev Gastroenterol Disord 4:1–6
Logan RP (1993) Urea breath tests for the detection of Helicobacter-pylori infection. Eur J Gastroenterol Hepatol 5:S46–S49
Cutler AF, Elnaggar M, Brooks E, O’Mara K (1998) Effect of standard and high dose ranitidine on [13C]urea breath test results. Am J Gastroenterol 93:1297–1299
Ozturk E, Yesilova Z, Ilgan S, Ozguven M, Dagalp K (2009) Performance of acidified 14C-urea capsule breath test during pantoprazole and ranitidine treatment. J Gastroenterol Hepatol 24:1248–1251
Desroches JJ, Lahaie RG, Picard M et al (1997) Methodological validation and clinical usefulness of carbon-14-urea breath test for documentation of presence and eradication of Helicobacter pylori infection. J Nucl Med 38:1141–1145
Marshall BJ, Plankey MW, Hoffman SR et al (1991) A 20-minute breath test for Helicobacter pylori. Am J Gastroenterol 86:438–445
Rollan A, Giancaspero R, Arrese M et al (1997) Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection after antibiotic treatment. Am J Gastroenterol 92:1268–1274
Abukhadir BA, Heneghan MA, Kearns M, Little CL, McCarthy CF (1998) Evaluation of a 20 minute 14C urea breath test for the diagnosis of Helicobacter pylori infection. Ir Med J 91:23–25
Kao CH, Huang CK, Wang SJ, Hsu CY, Lin WY, Chen GH (1993) Accuracy of a rapid 10-minute carbon-14 urea breath test for the diagnosis of Helicobacter pylori-associated peptic ulcer disease. Eur J Nucl Med 20:708–711
Hegedus O, Ryden J, Rehnberg AS, Nilsson S, Hellstrom PM (2002) Validated accuracy of a novel urea breath test for rapid Helicobacter pylori detection and in-office analysis. Eur J Gastroenterol Hepatol 14:513–520
Raju GS, Smith MJ, Morton D, Bardhan KD (1994) Mini-dose (1-microCi) 14C-urea breath test for the detection of Helicobacter pylori. Am J Gastroenterol 89:1027–1031
Ozturk E, Yesilova Z, Ilgan S et al (2003) A new, practical, low-dose 14C-urea breath test for the diagnosis of Helicobacter pylori infection: clinical validation and comparison with the standard method. Eur J Nucl Med Mol Imaging 30:1457–1462
Peura DA, Pambianco DJ, Dye KR et al (1996) Microdose 14C-urea breath test offers diagnosis of Helicobacter pylori in 10 minutes. Am J Gastroenterol 91:233–238
Pathak CM, Kaur B, Khanduja KL (2010) 14C-urea breath test is safe for pediatric patients. Nucl Med Commun 31:830–835
Gunnarsson M, Leide-Svegborn S, Stenstrom K et al (2002) No radiation protection reasons for restrictions on 14C urea breath tests in children. Br J Radiol 75:982–986
Pathak CM, Avti PK, Bunger D, Khanduja KL (2008) Kinetics of 14carbon dioxide excretion from 14C-urea by oral commensal flora. J Gastroenterol Hepatol 23:1603–1607
Epple HJ, Kirstein FW, Bojarski C et al (1997) 13C-urea breath test in Helicobacter pylori diagnosis and eradication. Correlation to histology, origin of ‘false’ results, and influence of food intake. Scand J Gastroenterol 32:308–314
Liao CC, Lee CL, Chiang TC et al (2002) The 13C-urea breath test to detect Helicobacter pylori infection: a validated simple methodology with 50 mg 13C-urea. Aliment Pharmacol Ther 16:787–792
Ohara S, Kato M, Saito M et al (2004) Comparison between a new 13C-urea breath test, using a film-coated tablet, and the conventional 13C-urea breath test for the detection of Helicobacter pylori infection. J Gastroenterol 39:621–628
Oksanen A, Bergstrom M, Sjostedt S, Gad A, Hammarlund B, Seensalu R (1997) Accurate detection of Helicobacter pylori infection with a simplified 13C urea breath test. Scand J Clin Lab Invest 57:689–694
Peng NJ, Lai KH, Liu RS et al (2001) Clinical significance of oral urease in diagnosis of Helicobacter pylori infection by [13C]urea breath test. Dig Dis Sci 46:1772–1778
Lee HS, Gwee KA, Teng LY et al (1998) Validation of [13C]urea breath test for Helicobacter pylori using a simple gas chromatograph-mass selective detector. Eur J Gastroenterol Hepatol 10:569–572
Thomas JE, Dale A, Harding M et al (1999) Interpreting the 13C-urea breath test among a large population of young children from a developing country. Pediatr Res 46:147–151
Braden B, Caspary WF, Lembcke B (1999) Nondispersive infrared spectrometry for 13CO2/12CO2-measurements: a clinically feasible analyzer for stable isotope breath tests in gastroenterology. Z Gastroenterol 37:477–481
Isomoto H, Inoue K, Mizuta Y et al (2003) Validation of endoscopic 13C-urea breath test with nondispersive infrared spectrometric analysis in the management of Helicobacter pylori infection. Hepatogastroenterology 50:422–425
Kato M, Saito M, Fukuda S et al (2004) 13C-Urea breath test, using a new compact nondispersive isotope-selective infrared spectrophotometer: comparison with mass spectrometry. J Gastroenterol 39:629–634
Savarino V, Mela GS, Zentilin P et al (1999) Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test. Am J Gastroenterol 94:1203–1208
Braden B, Gelbmann C, Dietrich CF, Caspary WF, Scholmerich J, Lock G (2001) Qualitative and quantitative clinical evaluation of the laser-assisted ratio analyser for detection of Helicobacter pylori infection by (13)C-urea breath tests. Eur J Gastroenterol Hepatol 13:807–810
Murnick DE, Peer BJ (1994) Laser-based analysis of carbon isotope ratios. Science 263:945–947
Shirin H, Kenet G, Shevah O et al (2001) Evaluation of a novel continuous real time (13)C urea breath analyser for Helicobacter pylori. Aliment Pharmacol Ther 15:389–394
Cave DR, Zanten SV, Carter E et al (1999) A multicentre evaluation of the laser assisted ratio analyser (LARA): a novel device for measurement of 13CO2 in the 13C-urea breath test for the detection of Helicobacter pylori infection. Aliment Pharmacol Ther 13:747–752
Minoli G, Prada A, Schuman R, Murnick D, Rigas B (1998) A simplified urea breath test for the diagnosis of Helicobacter pylori infection using the LARA System. Laser assisted ratio analyzer. J Clin Gastroenterol 26:264–266
Savarino V, Landi F, Dulbecco P et al (2000) Isotope ratio mass spectrometry (IRMS) versus laser-assisted ratio analyzer (LARA): a comparative study using two doses of. Dig Dis Sci 45:2168–2174
Graham DY, Klein PD, Evans DJ Jr et al (1987) Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet 1:1174–1177
Labenz J, Barsch G, Peitz U et al (1996) Validity of a novel biopsy urease test (HUT) and a simplified 13C-urea breath test for diagnosis of Helicobacter pylori infection and estimation of the severity of gastritis. Digestion 57:391–397
Hamlet A, Stage L, Lonroth H, Cahlin C, Nystrom C, Pettersson A (1999) A novel tablet-based 13C urea breath test for Helicobacter pylori with enhanced performance during acid suppression therapy. Scand J Gastroenterol 34:367–374
Gatta L, Vakil N, Ricci C et al (2003) A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment. Aliment Pharmacol Ther 17:793–798
Wong WM, Lam SK, Lai KC et al (2003) A rapid-release 50-mg tablet-based 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther 17:253–257
Wong WM, Wong BC, Wong KW et al (2000) (13)C-urea breath test without a test meal is highly accurate for the detection of Helicobacter pylori infection in Chinese. Aliment Pharmacol Ther 14:1353–1358
Dominguez-Munoz JE, Leodolter A, Sauerbruch T, Malfertheiner P (1997) A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut 40:459–462
Gisbert JP, Vazquez MA, Jimenez I et al (2000) 13C-urea breath test for the diagnosis of Helicobacter pylori infection before treatment: is citric acid necessary? Dig Liver Dis 32:20–24
Kopacova M, Bures J, Vorisek V et al (2005) Comparison of different protocols for 13C-urea breath test for the diagnosis of Helicobacter pylori infection in healthy volunteers. Scand J Clin Lab Invest 65:491–498
Leodolter A, Dominguez-Munoz JE, Von Arnim U, Malfertheiner P (1999) Citric acid or orange juice for the 13C-urea breath test: the impact of pH and gastric emptying. Aliment Pharmacol Ther 13:1057–1062
Graham DY (1998) Gastrin sensitivity and acid in H. pylori: revisited. Gastroenterology 115:509–510
Miederer SE, Grubel P (1996) Profound increase of Helicobacter pylori urease activity in gastric antral mucosa at low pH. Dig Dis Sci 41:944–949
Suto H, Azuma T, Ito S et al (1999) Evaluation of endoscopic 13C-urea breath test for assessment of Helicobacter pylori eradication. J Gastroenterol 34(Suppl 11):67–71
Wildner-Christensen M, Touborg Lassen A, Lindebjerg J, Schaffalitzky de Muckadell OB (2002) Diagnosis of Helicobacter pylori in bleeding peptic ulcer patients, evaluation of urea-based tests. Digestion 66:9–13
Zevit N, Niv Y, Shirin H, Shamir R (2011) Age and gender differences in urea breath test results. Eur J Clin Invest 41(7):767–772
Kindermann A, Demmelmair H, Koletzko B, Krauss-Etschmann S, Wiebecke B, Koletzko S (2000) Influence of age on 13C-urea breath test results in children. J Pediatr Gastroenterol Nutr 30:85–91
Yang HR, Ko JS, Seo JK (2008) Does the diagnostic accuracy of the 13C-urea breath test vary with age even after the application of urea hydrolysis rate? Helicobacter 13:239–244
Yoshimura N, Tajiri H, Sawada A et al (2001) A 13C-urea breath test in children with Helicobacter pylori infection: assessment of eradication therapy and follow-up after treatment. J Gastroenterol 36:606–611
Bazzoli F, Cecchini L, Corvaglia L et al (2000) Validation of the 13C-urea breath test for the diagnosis of Helicobacter pylori infection in children: a multicenter study. Am J Gastroenterol 95:646–650
Canete A, Abunaji Y, Alvarez-Calatayud G et al (2003) Breath test using a single 50-mg dose of 13C-urea to detect Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr 36:105–111
Kawakami E, Machado RS, Reber M, Patricio FR (2002) 13 C-urea breath test with infrared spectroscopy for diagnosing Helicobacter pylori infection in children and adolescents. J Pediatr Gastroenterol Nutr 35:39–43
Gao P, Korley F, Martin J, Chen BT (2002) Determination of unique microbial volatile organic compounds produced by five Aspergillus species commonly found in problem buildings. AIHA J (Fairfax, VA) 63:135–140
Syhre M, Scotter JM, Chambers ST (2008) Investigation into the production of 2-Pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples. Med Mycol 46:209–215
Chambers ST, Syhre M, Murdoch DR, McCartin F, Epton MJ (2009) Detection of 2-pentylfuran in the breath of patients with Aspergillus fumigatus. Med Mycol 47:468–476
Chambers ST, Bhandari S, Scott-Thomas A, Syhre M (2011) Novel diagnostics: progress toward a breath test for invasive Aspergillus fumigatus. Med Mycol 49:S54–S61
Scott-Thomas AJ, Syhre M, Pattemore PK et al (2010) 2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung. BMC Pulm Med 10:56
Syhre M, Manning L, Phuanukoonnon S, Harino P, Chambers ST (2009) The scent of Mycobacterium tuberculosis - Part II breath. Tuberculosis 89:263–266
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wang, S., Zhang, WM., Reineks, E. (2013). Breath Tests for Detection of Helicobacter pylori and Aspergillus fumigatus . In: Tang, YW., Stratton, C. (eds) Advanced Techniques in Diagnostic Microbiology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-3970-7_2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3970-7_2
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-3969-1
Online ISBN: 978-1-4614-3970-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)